Malaria Clinical Trials Center General Screening

Completed

Conditions studied: Malaria

In brief

The purpose of this study is to identify and screen potential subjects for preliminary eligibility to participate in a malaria related clinical trial conducted at the Seattle Malaria Clinical Trials Center (Seattle MCTC) or one of our partnering sites.

Key facts

Study ID

NCT02119312

Run by

Fred Hutchinson Cancer Center

People needed

2101

Starts

2010-06-01

Expected to finish

2020-09-01

Last updated by the study team

2020-09-14

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Good general health status as demonstrated by medical history, physical exam, and screening laboratory tests;
• No history of certain chronic medical illnesses (e.g. diabetes, epilepsy, autoimmune disease, hepatitis, heart disease);
• HIV, Hepatitis B and C negative;
• Low risk for coronary heart disease;
• Ability and willingness to provide informed consent;
• Reliable access to the MCTC and associated sites; and
• If participant is biologically female she must not be pregnant and must agree to consistently use an effective form of birth control 21 days prior to enrollment in an active clinical study and for the duration of that study.

You may not qualify if…

• Prior receipt of an investigational malaria vaccine;
• Chronic use of systemic antibiotics or immunosuppressive medications with anti-malarial effects;
• Chronic medical condition, physical examination findings, other clinically significant abnormal laboratory results, or past medical history that may have clinically significant implications for current health status;
• History of systemic anaphylaxis;
• History of, or known active cardiac disease;
• Elevated (moderate of high) risk of coronary heart disease;
• Clinically significant ECG findings;
• Chronic or active neurological disease;
• History of splenectomy or functional asplenia;
• History of psoriasis or porphyria;
• History of diagnosed ocular disease;
• Positive history of HIV, Hepatitis B and/or C;
• Pregnant or lactating females or females who intend to become pregnant during study period;
• Certain psychiatric conditions that could affect study compliance; and
• Suspected or known current alcohol and/or drug abuse.

Where it is running

• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.